GI Joe Gastroenterology Rounds Podcast Por Joseph Kumka arte de portada

GI Joe Gastroenterology Rounds

GI Joe Gastroenterology Rounds

De: Joseph Kumka
Escúchala gratis

I'm Dr. Joseph Kumka, Gastroenterology Fellow, educator, and creator of this podcasts. Whether you're a resident gearing up for the boards, a fellow diving deep into subspecialty topics, or a practicing clinician hungry for high-yield updates—you’re in the right place. Subscribe, engage, and let's raise the bar together.2025
Episodios
  • Citywide Conference - Cholangitis

    Citywide Conference - Cholangitis
    Jul 18 2025
    Biliary Infection and Cholangitis ManagementThis briefing document summarizes key information regarding biliary infection and cholangitis management, based on the provided excerpts from "Biliary Infection and Cholangitis Management." It highlights essential concepts for early recognition, grading, treatment planning, and error avoidance.1. Introduction and Importance of Early RecognitionCholangitis is a life-threatening condition that, when first described by Dr. Charcot, had a mortality rate of about 50%. While now treatable, it remains a serious concern. It is a very common, urgent consult and requires prompt recognition due to its potential to rapidly spiral into sepsis and multi-system organ failure. Early recognition is crucial for effective management and improved patient outcomes.2. Pathophysiology and Common CausesCholangitis results from an obstructed biliary tree, which increases pressure within the ducts. This increased pressure makes the ductal epithelium "leaky," increasing permeability and allowing bacteria to enter the portal and systemic circulation. While bile in healthy individuals is often sterile, interventions on the biliary system (e.g., prior sphincterotomy or surgery) can disrupt mechanisms that keep bile clean. This allows bacteria to multiply, especially when there's a foreign body like a stent or a stone, which acts as a "nidus" for bacterial growth.Common causes of obstruction leading to cholangitis include:Stones (Choledocholithiasis): These remain the top factors, accounting for up to 70% of cases.Malignancies/Tumors: Increasing due to an older population requiring various treatments. This includes cholangiocarcinoma, pancreatic head masses, and other processes in the pre-ampullary region.Post-surgical anatomyStents: Stents, while used for drainage, can become contaminated and obstructed, leading to cholangitis. As noted, "It's not until we instrument them, right, put a stent in that they can later present with cholangitis because they're stent foods."Common bacteria involved are typically gut flora, such as E. coli, Klebsiella, and other Gram-negative and anaerobic bacteria.3. Clinical Presentation and DiagnosisCharcot's Triad is the classic textbook presentation, consisting of:FeverRight upper quadrant abdominal painJaundiceHowever, only about 50% of patients present with this complete triad. Reynold's Pentad, which includes Charcot's Triad plus hypotension and altered mental state, is usually indicative of severe disease.It's important to note that elderly patients can have atypical presentations, possibly with isolated hypotension or altered mental status, similar to a UTI in the elderly.Diagnostic Approach:Labs: Blood cultures are essential and should be drawn prior to antibiotic initiation. Other important labs include CRP, bilirubin, and cholestatic enzymes (e.g., AST, ALT).Imaging:Abdominal Ultrasound: The test of choice for initial imaging due to its ease, safety, and effectiveness in detecting duct dilation and stones. If dilation or a stone is visible and skills are trusted, diagnosis can be complete.CT Scan: Not ideal for stones but good for identifying other etiologies (e.g., masses) and duct dilation.MRCP (Magnetic Resonance Cholangiopancreatography): Helpful for malignant strictures but not always needed.EUS (Endoscopic Ultrasound): Becoming a "great instrument," especially in expert hands, for patients who cannot undergo radiation imaging (e.g., pregnant patients). It allows for "hydrid diagnosis therapy with EUS ERCP concept" and can be used at the bedside for unstable ICU patients to rule out obstruction, potentially avoiding unnecessary ERCPs. EUS is a highly sensitive test for ruling out obstruction.Tokyo Guidelines for Diagnosis: These guidelines provide an algorithm requiring:One systemic evidence: Fever, leukocytosis, or other laboratory abnormality (e.g., elevated CRP).One cholestatic evidence: Total bilirubin > 2 mg/dL or elevated cholestatic enzymes (e.g., ALP, GGT).One imaging evidence: Duct dilation or identified cause of obstruction (e.g., stone, mass). Meeting these criteria provides a "strong diagnosis."4. Grading Severity and Management PlanningThe severity grading of cholangitis, typically using the Tokyo Guidelines, is crucial because it dictates the urgency of drainage and overall management.Grade 1 (Mild):Criteria: No signs of organ dysfunction.Management: Medical treatment first (antibiotics, hydration, pain management). Drainage can wait. Intervention may not be needed if a clear etiology to remove is not present (e.g., no stone to extract, no stent to replace).Grade 2 (Moderate):Criteria: Two or more "warning signs," including high fever, age ≥ 75, WBC < 4,000 or > 12,000, bilirubin > 5 mg/dL, or hypoalbuminemia.Management: Requires early drainage (within 24-48 hours).Grade 3 (Severe):Criteria: Organ failure/dysfunction (e.g., hypotension requiring pressors, respiratory failure requiring oxygen/ventilation, kidney injury, liver ...
    Más Menos
    20 m
Todavía no hay opiniones